{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:30:48Z","timestamp":1790699448447,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.leukres.2019.106180","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T12:39:24Z","timestamp":1562157564000},"page":"106180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Interleukin-8 blockade prevents activated endothelial cell mediated proliferation and chemoresistance of acute myeloid leukemia"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7886-7443","authenticated-orcid":false,"given":"Vindhya","family":"Vijay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regan","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gau Shoua","family":"Vue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mida Bahareh","family":"Pezeshkian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maywood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison M.","family":"Ast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leylah M.","family":"Drusbosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Pompeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel D.","family":"Lipten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Geddes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Marie","family":"Blenc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Ostrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5422-6863","authenticated-orcid":false,"given":"Christopher R.","family":"Cogle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard J.","family":"Madlambayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.leukres.2019.106180_bib0005","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1182\/blood-2005-01-0178","article-title":"Drug therapy for acute myeloid leukemia","volume":"106","author":"Tallman","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2019.106180_bib0010","doi-asserted-by":"crossref","first-page":"375857","DOI":"10.4061\/2011\/375857","article-title":"Osteoblastic and vascular endothelial niches, their control on normal hematopoietic stem cells, and their consequences on the development of leukemia","volume":"2011","author":"Guerrouahen","year":"2011","journal-title":"Stem Cells Int."},{"issue":"1","key":"10.1016\/j.leukres.2019.106180_bib0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/leu.2011.236","article-title":"The vascular niche: home for normal and malignant hematopoietic stem cells","volume":"26","author":"Doan","year":"2012","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.leukres.2019.106180_bib0020","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.stem.2007.06.001","article-title":"Lack of evidence that hematopoietic stem cells depend on N-cadherin-mediated adhesion to osteoblasts for their maintenance","volume":"1","author":"Kiel","year":"2007","journal-title":"Cell Stem Cell"},{"issue":"10","key":"10.1016\/j.leukres.2019.106180_bib0025","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1038\/leu.2014.109","article-title":"Functional integration of acute myeloid leukemia into the vascular niche","volume":"28","author":"Cogle","year":"2014","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.leukres.2019.106180_bib0030","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1182\/blood-2009-06-230474","article-title":"Leukemia regression by vascular disruption and antiangiogenic therapy","volume":"116","author":"Madlambayan","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2019.106180_bib0035","doi-asserted-by":"crossref","first-page":"e60823","DOI":"10.1371\/journal.pone.0060823","article-title":"Leukemia mediated endothelial cell activation modulates leukemia cell susceptibility to chemotherapy through a positive feedback loop mechanism","volume":"8","author":"Pezeshkian","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.leukres.2019.106180_bib0040","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/ijc.22180","article-title":"Microvascular endothelial cells increase proliferation and inhibit apoptosis of native human acute myelogenous leukemia blasts","volume":"119","author":"Hatfield","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.leukres.2019.106180_bib0045","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1182\/blood.V89.8.2782","article-title":"Human platelets as a model for the binding and degradation of thrombopoietin","volume":"89","author":"Fielder","year":"1997","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2019.106180_bib0050","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1177\/0192623310378866","article-title":"Biomarkers of endothelial cell activation serve as potential surrogate markers for drug-induced vascular injury","volume":"38","author":"Zhang","year":"2010","journal-title":"Toxicol. Pathol."},{"issue":"9","key":"10.1016\/j.leukres.2019.106180_bib0055","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nri2156","article-title":"Getting to the site of inflammation: the leukocyte adhesion cascade updated","volume":"7","author":"Ley","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.leukres.2019.106180_bib0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1034\/j.1600-0609.2003.00080.x","article-title":"Effects of angiogenic regulators on in vitro proliferation and cytokine secretion by native human acute myelogenous leukemia blasts","volume":"71","author":"Bruserud","year":"2003","journal-title":"Eur. J. Haematol."},{"issue":"4","key":"10.1016\/j.leukres.2019.106180_bib0065","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1684\/ecn.2012.0322","article-title":"The angioregulatory cytokine network in human acute myeloid leukemia\u2014from leukemogenesis via remission induction to stem cell transplantation","volume":"23","author":"Reikvam","year":"2012","journal-title":"Eur. Cytokine Netw."},{"issue":"1","key":"10.1016\/j.leukres.2019.106180_bib0070","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/leu.2008.255","article-title":"Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors","volume":"23","author":"Negaard","year":"2009","journal-title":"Leukemia"},{"issue":"20","key":"10.1016\/j.leukres.2019.106180_bib0075","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1182\/blood-2015-01-621631","article-title":"IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells","volume":"125","author":"Schinke","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2019.106180_bib0080","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pep.2009.06.010","article-title":"High level expression and purification of active recombinant human interleukin-8 in Pichia pastoris","volume":"68","author":"Li","year":"2009","journal-title":"Protein Exp. Purif."},{"issue":"28","key":"10.1016\/j.leukres.2019.106180_bib0085","doi-asserted-by":"crossref","first-page":"18989","DOI":"10.1016\/S0021-9258(18)55160-7","article-title":"Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding","volume":"266","author":"Hebert","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.leukres.2019.106180_bib0090","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood.V97.7.2121","article-title":"Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination","volume":"97","author":"Stucki","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2019.106180_bib0095","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0268-960X(92)90026-M","article-title":"Autocrine growth factors and leukaemic haemopoiesis","volume":"6","author":"Russell","year":"1992","journal-title":"Blood Rev."},{"issue":"1","key":"10.1016\/j.leukres.2019.106180_bib0100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000065722","article-title":"Circulating levels of thrombopoietic and inflammatory cytokines in patients with acute myeloblastic leukemia and myelodysplastic syndrome","volume":"63","author":"Hsu","year":"2002","journal-title":"Oncology"},{"issue":"5","key":"10.1016\/j.leukres.2019.106180_bib0105","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/10245332.2000.11746533","article-title":"Implication of granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-3 (IL-3) in children with acute myeloid leukaemia (AML); malignancy","volume":"5","author":"Elbaz","year":"2001","journal-title":"Hematology"},{"issue":"6","key":"10.1016\/j.leukres.2019.106180_bib0110","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1006\/cyto.2000.0666","article-title":"SCF, IL-1beta, IL-1ra and GM-CSF in the bone marrow and serum of normal individuals and of AML and CML patients","volume":"12","author":"Tao","year":"2000","journal-title":"Cytokine"},{"issue":"7","key":"10.1016\/j.leukres.2019.106180_bib0115","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/cncr.23785","article-title":"The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes","volume":"113","author":"Tsimberidou","year":"2008","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.leukres.2019.106180_bib0120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.leu.2404985","article-title":"Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levels","volume":"22","author":"Hatfield","year":"2008","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.leukres.2019.106180_bib0125","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4161\/mabs.1.5.9288","article-title":"Anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia","volume":"1","author":"Sutherland","year":"2009","journal-title":"MAbs"},{"issue":"1","key":"10.1016\/j.leukres.2019.106180_bib0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/mcbr.2000.0190","article-title":"Induction and secretion of the chemokines interleukin-8 and monocyte chemotactic protein-1 in human immature leukemia cell lines","volume":"3","author":"Steube","year":"2000","journal-title":"Mol. Cell Biol. Res. Commun."},{"issue":"12","key":"10.1016\/j.leukres.2019.106180_bib0135","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/leu.2009.175","article-title":"Contribution of bone microenvironment to leukemogenesis and leukemia progression","volume":"23","author":"Ayala","year":"2009","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.leukres.2019.106180_bib0140","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood.V95.1.309","article-title":"Evidence of increased angiogenesis in patients with acute myeloid leukemia","volume":"95","author":"Hussong","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2019.106180_bib0145","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/annonc\/mdh017","article-title":"Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients","volume":"15","author":"Beerepoot","year":"2004","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.leukres.2019.106180_bib0150","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood.V97.11.3658","article-title":"Resting and activated endothelial cells are increased in the peripheral blood of cancer patients","volume":"97","author":"Mancuso","year":"2001","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2019.106180_bib0155","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-0609.2007.00839.x","article-title":"Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia","volume":"78","author":"Rigolin","year":"2007","journal-title":"Eur. J. Haematol."},{"issue":"21","key":"10.1016\/j.leukres.2019.106180_bib0160","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","article-title":"The interleukin-8 pathway in cancer","volume":"14","author":"Waugh","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.leukres.2019.106180_bib0165","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/aps.2016.121","article-title":"The PI3K\/mTOR dual inhibitor BEZ235 suppresses proliferation and migration and reverses multidrug resistance in acute myeloid leukemia","volume":"38","author":"Deng","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.leukres.2019.106180_bib0170","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.blre.2017.11.006","article-title":"Dueling for dual inhibition: means to enhance effectiveness of PI3K\/Akt\/mTOR inhibitors in AML","volume":"32","author":"Herschbein","year":"2018","journal-title":"Blood Rev."},{"issue":"53","key":"10.1016\/j.leukres.2019.106180_bib0175","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.1038\/sj.onc.1204984","article-title":"The protein kinase PKB\/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change","volume":"20","author":"Yamaguchi","year":"2001","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.leukres.2019.106180_bib0180","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1182\/blood-2003-01-0211","article-title":"Cleavage of Bax to p18 Bax accelerates stress-induced apoptosis, and a cathepsin-like protease may rapidly degrade p18 Bax","volume":"102","author":"Cao","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2019.106180_bib0185","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1046\/j.1471-4159.2001.00368.x","article-title":"Cleavage of Bax is mediated by caspase-dependent or -independent calpain activation in dopaminergic neuronal cells: protective role of Bcl-2","volume":"77","author":"Choi","year":"2001","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.leukres.2019.106180_bib0190","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1182\/blood.V82.8.2517.2517","article-title":"Constitutive expression of interleukin-8 and its receptor in human myeloid and lymphoid leukemia","volume":"82","author":"Tobler","year":"1993","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2019.106180_bib0195","first-page":"391","article-title":"Osteoblasts increase proliferation and release of pro-angiogenic interleukin 8 by native human acute myelogenous leukemia blasts","volume":"89","author":"Bruserud","year":"2004","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.leukres.2019.106180_bib0200","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1182\/blood.V95.8.2637","article-title":"Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia","volume":"95","author":"Padro","year":"2000","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2019.106180_bib0205","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1182\/blood.V94.11.3717","article-title":"Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia","volume":"94","author":"Aguayo","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2019.106180_bib0210","doi-asserted-by":"crossref","first-page":"18411","DOI":"10.1038\/srep18411","article-title":"IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia","volume":"5","author":"Kuett","year":"2015","journal-title":"Sci. Rep."},{"issue":"18","key":"10.1016\/j.leukres.2019.106180_bib0215","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1158\/1078-0432.CCR-16-2748","article-title":"Phase Ib pilot study to evaluate reparixin in combination with weekly paclitaxel in patients with HER-2-negative metastatic breast cancer","volume":"23","author":"Schott","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.leukres.2019.106180_bib0220","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cytogfr.2016.08.002","article-title":"The CXCL8-CXCR1\/2 pathways in cancer","volume":"31","author":"Liu","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"issue":"3","key":"10.1016\/j.leukres.2019.106180_bib0225","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB signaling: navigating the network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"issue":"19","key":"10.1016\/j.leukres.2019.106180_bib0230","doi-asserted-by":"crossref","first-page":"14056","DOI":"10.1074\/jbc.M700906200","article-title":"RAS\/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation","volume":"282","author":"Roux","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.leukres.2019.106180_bib0235","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1158\/1078-0432.CCR-10-0433","article-title":"Targeting eukaryotic translation initiation factor 4E (eIF4E) in cancer","volume":"16","author":"Hsieh","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.leukres.2019.106180_bib0240","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1182\/blood-2006-04-016907","article-title":"Role of phosphatidylinositol 3\u2019-kinase\/AKT pathway in diffuse large B-cell lymphoma survival","volume":"108","author":"Uddin","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2019.106180_bib0245","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.molcel.2004.11.014","article-title":"Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak","volume":"16","author":"Majewski","year":"2004","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.leukres.2019.106180_bib0250","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.1074\/jbc.274.12.8309","article-title":"Caspase-dependent activation of calpain during drug-induced apoptosis","volume":"274","author":"Wood","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.leukres.2019.106180_bib0255","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/1097-4644(20010101)80:1<53::AID-JCB60>3.0.CO;2-E","article-title":"N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome C release and apoptotic cell death","volume":"80","author":"Gao","year":"2000","journal-title":"J. Cell. Biochem."},{"issue":"6059","key":"10.1016\/j.leukres.2019.106180_bib0260","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.1206727","article-title":"Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy","volume":"334","author":"Ni Chonghaile","year":"2011","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.leukres.2019.106180_bib0265","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S1734-1140(09)70093-3","article-title":"Effect of interleukin 6 deficiency on the expression of Bcl-2 and Bax in the murine heart","volume":"61","author":"Kaminski","year":"2009","journal-title":"Pharmacol. Rep."},{"issue":"4","key":"10.1016\/j.leukres.2019.106180_bib0270","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1165\/rcmb.2002-0262OC","article-title":"Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs","volume":"29","author":"Moodley","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.leukres.2019.106180_bib0275","doi-asserted-by":"crossref","first-page":"32428","DOI":"10.1038\/srep32428","article-title":"The oncometabolite R-2-hydroxyglutarate activates NF-kappaB-dependent tumor-promoting stromal niche for acute myeloid leukemia cells","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212619301250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212619301250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:59:37Z","timestamp":1758934777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212619301250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":55,"alternative-id":["S0145212619301250"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2019.106180","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-8 blockade prevents activated endothelial cell mediated proliferation and chemoresistance of acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2019.106180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106180"}}